Program

 APACC 2017 will feature some of region's most prominent and distinguished leaders that will discuss the most current and trending issues in the field. Delegates can look forward to an exciting and highly interactive program that will inspire and promote new pathways to advancing the field.

Below the preliminary program for the International workshop on APACC 2017 is published. Please note that thisprogram is subject to change.

Please download the latest version of the program here. (version 2017-05-24)

Thursday 1 June 2017

(version 2017-03-31)

12.00 - 13.30Registration & Walk-in Lunch
 
13.30 - 14.00 Opening Ceremony
14.00 Key note lecture: HIV/AIDS in the Asia Pacific:  Where is the Epidemic Heading?
Chris Beyrer, MD, MPH
JHU Center for AIDS Research, Baltimore, USA
 
  Plenary session 1: Asian Specific Barriers to Cascade of Care
14.30 Perspective Program Implementer
15.00 Perspective Community
Martin Choo, MMedSc

AIDS Support Services Society (KLASS), Asia Pacific Council of AIDS Service Organizations (APCASO), Kuala Lumpur, Malaysia
15.30 Discussion
 
16.00Coffee Break
 
 Parallel session 1: Point of Care testing 
16.30 POC testing for early infant diagnosis
17.00Innovative ways to stimulate the demand HIV and HCV testing
Philip Cunningham, MD
The Kirby Institute, UNSW Sydney, Sydney, Australia
17.30 Discussion
 
  Parallel session 2: Opportunistic Infections 
16.30 What's new in the management of fungal opportunistic infections"
Thuy Le, MD, Dphil
The Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, the Hospital for Tropical Diseases, Ho Chi Min City, Vietnam
17.00 Identifying TB co-infection - new approaches
Charoen Chuchottaworn, MD
Central Chest in Nonthaburi, Nonthaburi, Thailand
17.30 Discussion
 
  Parallel session 3: Emerging ART management paradigms – are 2 drugs enough? 
16.30 Gardel study
Pedro Cahn, MD, PhD
Huesped Foundation, Ciudad Autónoma de Buenos Aires, Argentina
17.00 SWORD study
Chien-Ching Hung, MD, PhD
National Taiwan University College of Medicine, Taiwan
17.30 Discussion
 
  Industry sponsored symposium slot
18.00 - 19.00 Presentations
 
19.00Best Abstract Award Ceremony & Welcome Reception
 

Friday 2 June 2017

 
  Industry sponsored symposium slot
08.00 - 09.00 Presentations
 
  Plenary session 2: Challenges in long-term HIV Care
09.00 Mental health and neurocognitive issues related to adolescents who have grown up with HIV
Warren Y.K. Ng, MD, MPH
Columbia University Medical Center, New York, USA
09.30Aging among adults in the context of HIV
Reena Rajasuriar , Mpharm, PhD
University of Malaya, Kuala Lumpur, Malaysia
10.00 Neurocognitive issues among aging adults
Edwina Wright, MD, PhD
Burnet Institute, Melbourne, Australia
 
10.30Coffee Break
 
  Parallel session 4:Treatment Failures and Resistance
11.00 Resistance testing for selecting second line drugs
Nicholas Paton, MD, FRCP
National University of Singapore, Singapore
11.30 Does resistance still matter
Dan Kuritzkes, MD
Harvard Medical School, Boston, MA, USA , Boston, USA
12.30 Clinical Case presentation
Chien-Ching Hung, MD, PhD
National Taiwan University College of Medicine, Tapei City, Taiwan, Tapei City, Taiwan
13.00 Discussion
 
  Parallel session 5: Hepatitis HIV Co-infection
11.00 Outbreak of Hepatitis A among HIV-infected men who have sex with men in Hong Kong
Bonnie Wong , MD
Kowloon Bay Integrated Treatment Centre, Hong Kong
11.30 HIV and intestinal co-infection
Ivan FN Hung, MBChB, MD, FRCP, FHKCP, FHKAM, PDipID
The University of Hong Kong, Hong Kong
11.30 - 13.00 Invited lectures & abstract driven presentations
  Parallel session 6: Capacity Building: How to design clin.trials/cohort
11.00 - 13.00 Invited lectures & abstract driven presentations
 
13.00Lunch Break
 
  Parallel session 7: Key Populations 
14.00

HIV and Adolescents: how do we help them to prepare for adult life

14.30 HIV epidemiology among TG individuals
15.00 HIV prevention and linkage for TGW and TGM
15.30 Lecture on MSM (Chinese University Hong Kong)
 
  Parallel session 8: Co-morbidities (non-AIDS events)
14.00 Renal disease and HIV
Sanjay Pujari, MD, MBBS
Institute of Infectious Diseases, Pune, India
14.30 Cardiovascular disease and HIV
Somnuek Sunkanuparph, MD
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
15.00 Invited lectures or abstract driven presentations
 
  Parallel session 9: Technology-based HIV service delivery models 
14.00 Recruiting people into HIV Services: eBooking
Panus Na Nakorn, PhD
Thai Red Cross AIDS Research Centre, Bangkok, Thailand
14.30 Online platforms to spur HIV Testing
Joe Tucker, MD, PhD, AM
UNC School of Medicine, Chapital Hill, USA
15.00 E-Cascade for real-time monitoring of HIV program
Matthew Avery, MPH
FHI 360, Krung Thep Maha Nakhon, Thailand
15.30 Discussion
 
16.00Coffee Break
 
  Plenary session 3: Implementation of PrEP
  Introduction
Nittaya Phanuphak, MD, PhD
Thai Red Cross AIDS Research Centre, Thailand
14.00 Why PrEP is still being questioned
Andrew Grulich, MBBS, PhD
The Kirby Institute, UNSW Sydney, Sydney, Australia
14.30 RT: True demand from the communities
Midnight Poonkasetwattana, MSc
Asia Pacific Coalition on Male Sexual Health (APCOM), Bangkok, Thailand
15.00 RT: Genuine supply from the provider
Rossana Ditangco, MD
Research Institute for Tropical Medicine, Metro Manila, Philippines
15.30 PrEP research and implementation gaps
Michael Cassell, PhD, MA, MEM
USAID, Bangkok, Thailandxx
  Wrap-Up
Nittaya Phanuphak, MD, PhD
Thai Red Cross AIDS Research Centre, Thailand
 
  Industry sponsored symposium slot
18.00 - 19.00 Presentations
 

Saturday 3 June 2017

 
  Industry sponsored symposium slot
08.00 - 09.00 Presentations
 
  Plenary session 4: Access to Hepatitis C treatment in the region 
09.00 Access to treatment/care on global level
Margaret Hellard , MBBS, FRACP, FAFPHM, PhD
Burnet Institute, Melbourne, Australia
10.00 Access to treatment/care on country level
Giten Khwairakpam
TREAT Asia, Bangkok, Thailand
 
10.30Coffee Break
 
  Plenary session 5: New drugs on the Horizon
11.00 Hew HIV Drugs/Regimes
Daniel Kuritzes, MD
Harvard Medical School, Boston, USA
11.30 New Hepatitis Drugs
Jürgen Rockstroh, MD
University of Bonn, Bonn, Germany
12.00 New TB drugs
Nicholas Paton, MD, FRCP
National University of Singapore, Singapore
 
12.30 - 13.00Closure of the Conference